Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell TransplantationJonathan U. Peled, João B. Xavier, Annelie Clurman et al.|New England Journal of Medicine|2020Cited by 739
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityZachariah DeFilipp, Yi‐Bin Chen, Jonathan U. Peled et al.|Blood Advances|2018Cited by 206
Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell TransplantationJohn Tanaka, Matthew S. Kelly, Sarah M. Heston et al.|Biology of Blood and Marrow Transplantation|2020Cited by 57
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid LeukemiaMei Guo, Nelson J. Chao, Jianyong Li et al.|JAMA Oncology|2017Cited by 48
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic CancersElizabeth F. Krakow, Anthony D. Sung, Hui‐Sheng Ai et al.|Current Drug Targets|2015Cited by 16